Canine osteoarthritis is a progressive disease happening over time. According to canine osteoarthritis (OA) experts, the optimal management of OA focuses on strategies which can slow down the clock.3 Adequan® Canine is a disease-modifying osteoarthritis drug (DMOAD) which is proven to bind to and help promote key components of the cartilage matrix and inhibit damaging enzymes to help slow OA degradation in synovial joints. By treating the disease early in its cycle, there may be a profound positive impact on the progression and severity of the OA disease cycle over your dog’s lifetime.
A treatment program which focuses only on managing the signs of OA will not address the underlying
disease state responsible for causing the disease progression. Consult with your veterinarian to
determine the best treatment methods for your dog.